KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 3,340.00
+25.00 (0.75%)
At close: Aug 11, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 64.86 billion as of August 11, 2026. Its market cap has decreased by -35.40% in one year.
Market Cap
64.86B
Enterprise Value
51.17B
Revenue
71.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,340.00
ChartMarket Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 64.86B, a decrease of -86.85%. That is a compound annual growth rate of -29.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 64.86B | -41.71% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIO-FD&C | 72.17B |
| QuadMedicine | 70.04B |
| IMGT Co.,Ltd. | 68.33B |
| PanGen Biotech | 67.84B |
| AriBioLab | 67.51B |
| NovMetaPharma | 64.72B |
| J2KBIO | 61.75B |
| Naturalendo Tech | 60.15B |